Medical specialists from United Kingdom tagged as investigators in clinical trials studying Pancreatic Cancer

Total 122 results

Alan Christie
Seen in:
- Edinburgh, Western General
Trials:
- NCT04161417 (Principal Investigator)
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Alastair Greystoke, FRCP, PhD
Seen in:
- Newcastle, The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital
Trials:
- NCT03875820 (Principal Investigator)
Conditions:
Andreas Prachalias
Seen in:
- London, King's College Hospital
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Andrew Bateman
Seen in:
- Hampshire, Southampton, University Hospital Southampton NHS Foundation Trust, Southampton General Hospital
- Southampton, University Hospital Southampton
- Southampton, University of Southampton Hospital
Trials:
- NCT04161417 (Principal Investigator)
- NCT04151277 (Principal Investigator)
- NCT05965479 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic;
- Gastrooesophageal Cancer
Andrew Smith
Seen in:
- Lanarkshire, Airdrie, GSK Investigational Site
- Leeds, St James's Hospital
Trials:
- NCT04718389 (Principal Investigator)
- NCT04161417 (Principal Investigator)
Conditions:
- Asthma;
- Neoplasms Pancreatic
Anna-Mary Young
Seen in:
- London, St George's Hospital
Trials:
- NCT04161417 (Principal Investigator)
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Anthony Maraveyas
Seen in:
- Cottingham, Castle Hill Hospital
Trials:
- NCT04161417 (Principal Investigator)
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Arif Adnan Shaukat, MD
Seen in:
- Aberdeenshire, Aberdeen, Aberdeen Royal Infirmary
Trials:
- NCT04698915 (Principal Investigator)
Conditions:
Arora Arvind
Seen in:
- Nottingham, Nottingham University Hospital
- Nottingham, Nottingham University Hospitals NHS Trust
Trials:
- NCT04151277 (Principal Investigator)
- NCT05948475 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic;
- Cholangiocarcinoma
Arvind Arora
Seen in:
- Nottingham, Nottingham Hospitals NHS Trust
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Asa Dahle Smith
Seen in:
- Dundee, Ninewells Hospital
Trials:
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Asa Dahle-Smith
Seen in:
- Dundee, Ninewells Hospital
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Bassam Alkari
Seen in:
- Aberdeen, Aberdeen Royal Infirmary
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Bilal Al-Sarireh
Seen in:
- Swansea, Morriston Hospital
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Bill Greenhalf
Seen in:
- Liverpool, University of Liverpool
Trials:
- NCT04970056 (Principal Investigator)
Conditions:
Brinder Mahon, MD
Seen in:
- Birmingham, University Hospital Birmingham NHS FoundationTrust
Trials:
- NCT02343692 (Principal Investigator)
Conditions:
- Pancreatic Cyst
Bristi Basu
Seen in:
- Cambridge, Addenbrooke's Hospital
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Charlotte Manisty, PhD
Seen in:
- London, St Bartholomews Hospital
Trials:
- NCT06048458 (Principal Investigator)
Conditions:
Christian Ottensmeier, Prof
Seen in:
- Southampton, Cancer Research UK Centre, Southampton University Hospitals and University of Southampton
Trials:
- NCT02758587 (Principal Investigator)
Conditions:
Colin McKay
Seen in:
- Glasgow, Glasgow Royal Infirmary
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Daniel Hochhauser
Seen in:
- London, University College London Hospital
Trials:
- NCT04161417 (Principal Investigator)
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Daniel Palmer
Seen in:
- Liverpool, The Clatterbridge Cancer Centre
Trials:
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
David Landau, MBBS, MRCP
Seen in:
- London, Guy's and St Thomas' Hospital NHS Trust
Trials:
- NCT00346281 (Sub-Investigator)
Conditions:
- Pancreatic Cancer
David Propper
Seen in:
- London, St Bart's Hospital
Trials:
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Dean Fennell, Prof
Seen in:
- Leicester, Department of Cancer Studies, University of Leicester, Leicester Royal Infirmary
Trials:
- NCT02758587 (Principal Investigator)
Conditions:
Deb Sarker
Seen in:
- London, Guy's Hospital
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Debashis Sarker
Seen in:
- London, Guy's Hospital
Trials:
- NCT04151277 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Derek Grose, MD
Seen in:
- Glasgow, Beatson West of Scotland Cancer Centre
Trials:
- NCT04698915 (Principal Investigator)
Conditions:
Derek O'Reilly
Seen in:
- Manchester, Manchester Royal Infirmary
Trials:
- NCT04161417 (Principal Investigator)
Conditions:
- Neoplasms Pancreatic
Donald Milliken
Seen in:
- London, The Royal Marsden NHS Foundation Trust
Trials:
- NCT05831488 (Principal Investigator)
Conditions:

Clinical Trials on Pancreatic Cancer

City of Hope Medical Center

Recruiting

Pancreatic Cancer Detection Consortium (PCDC)

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditions

Korea, Republic of, United States, Japan
Sidney Kimmel Cancer Center at Thomas Jefferson...
Celgene

Withdrawn

Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy

Pancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
University of Nebraska
National Cancer Institute (NCI)

Completed

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer

Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study

Pancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic Carcinoma

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery

Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer
National Cancer Institute (NCI)

Completed

Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery

Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States
University of Utah
Novartis Pharmaceuticals

Recruiting

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer (THREAD)

Metastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer

United States
Shanghai Zhongshan Hospital
Fudan University

Not yet recruiting

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Pancreatic Cancer Stage III | Pancreatic Cancer, Stage IB | Pancreatic Cancer, Stage IIA | Pancreatic Cancer, Stage IIB

China
University of Wisconsin, Madison

Completed

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer

United States

Medical specialists from United Kingdom tagged as investigators in clinical trials studying Pancreatic Cancer

Clinical Trials on Pancreatic Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations